Back to top
more

Applied DNA Sciences (APDN)

(Real Time Quote from BATS)

$4.37 USD

4.37
60,626

-0.63 (-12.60%)

Updated Apr 26, 2024 03:42 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

F Value F Growth A Momentum F VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 37% (93 out of 252)

Industry: Security and Safety Services

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Allegion (ALLE) Q1 Earnings Surpass Estimates

by Zacks Equity Research

Allegion (ALLE) delivered earnings and revenue surprises of 9.93% and 2.33%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

Is Applied DNA Sciences (APDN) Outperforming Other Industrial Products Stocks This Year?

by Zacks Equity Research

Here is how Applied DNA Sciences (APDN) and Encore Wire (WIRE) have performed compared to their sector so far this year.

Applied DNA Sciences (APDN) Reports Q1 Loss, Tops Revenue Estimates

by Zacks Equity Research

Applied DNA Sciences (APDN) delivered earnings and revenue surprises of 70.97% and 27.29%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?

ADT (ADT) Q2 Earnings and Revenues Miss Estimates

by Zacks Equity Research

ADT (ADT) delivered earnings and revenue surprises of -30.43% and 2.88%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?

Proto Labs (PRLB) Q2 Earnings and Revenues Top Estimates

by Zacks Equity Research

Proto Labs (PRLB) delivered earnings and revenue surprises of 10% and 0.12%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?

Kennametal (KMT) Q4 Earnings and Revenues Miss Estimates

by Zacks Equity Research

Kennametal (KMT) delivered earnings and revenue surprises of -16.39% and 2.86%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?

Alarm.com Holdings (ALRM) Surpasses Q1 Earnings and Revenue Estimates

by Zacks Equity Research

Alarm.com (ALRM) delivered earnings and revenue surprises of 36.67% and 1.17%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

Clear Secure (YOU) Beats Q1 Earnings and Revenue Estimates

by Zacks Equity Research

Clear Secure (YOU) delivered earnings and revenue surprises of 300% and 2.03%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

Napco (NSSC) Beats Q3 Earnings and Revenue Estimates

by Zacks Equity Research

Napco (NSSC) delivered earnings and revenue surprises of 52.63% and 3.25%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

What Makes Applied DNA Sciences (APDN) a New Buy Stock

by Zacks Equity Research

Applied DNA Sciences (APDN) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

RBC Bearings (RBC) Q2 Earnings and Revenues Top Estimates

by Zacks Equity Research

RBC Bearings (RBC) delivered earnings and revenue surprises of 7.82% and 2.17%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

Alta Equipment (ALTG) Q3 Earnings and Revenues Surpass Estimates

by Zacks Equity Research

Alta Equipment (ALTG) delivered earnings and revenue surprises of 16.67% and 5.39%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

Alarm.com Holdings (ALRM) Q3 Earnings and Revenues Beat Estimates

by Zacks Equity Research

Alarm.com (ALRM) delivered earnings and revenue surprises of 10% and 2.62%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

Applied DNA Sciences (APDN) Reports Q3 Loss, Tops Revenue Estimates

by Zacks Equity Research

Applied DNA Sciences (APDN) delivered earnings and revenue surprises of 8.33% and 19.33%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

Energous (WATT) Reports Q2 Loss, Tops Revenue Estimates

by Zacks Equity Research

Energous (WATT) delivered earnings and revenue surprises of 12.50% and 22.63%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

ADT (ADT) Tops Q2 Earnings and Revenue Estimates

by Zacks Equity Research

ADT (ADT) delivered earnings and revenue surprises of 20% and 3.16%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

Applied DNA Sciences (APDN) Reports Q2 Loss, Tops Revenue Estimates

by Zacks Equity Research

Applied DNA Sciences (APDN) delivered earnings and revenue surprises of 6.67% and 32.19%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

New Strong Sell Stocks for February 15th

by Zacks Equity Research

ATGE, ALGN, and APDN have been added to the Zacks Rank #5 (Strong Sell) List on February 15, 2022

Applied DNA Sciences (APDN) Reports Q1 Loss, Lags Revenue Estimates

by Zacks Equity Research

Applied DNA Sciences (APDN) delivered earnings and revenue surprises of -231.58% and 2.62%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Napco (NSSC) Lags Q2 Earnings Estimates

by Zacks Equity Research

Napco (NSSC) delivered earnings and revenue surprises of -66.67% and 6.70%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Applied DNA Sciences (APDN) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

by Zacks Equity Research

Applied DNA Sciences (APDN) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Johnson Controls (JCI) Surpasses Q1 Earnings and Revenue Estimates

by Zacks Equity Research

Johnson Controls (JCI) delivered earnings and revenue surprises of 1.89% and 1.64%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Applied DNA Sciences (APDN) Reports Q4 Loss, Tops Revenue Estimates

by Zacks Equity Research

Applied DNA Sciences (APDN) delivered earnings and revenue surprises of -53.13% and 5.56%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

Applied DNA Sciences (APDN) Reports Q3 Loss, Lags Revenue Estimates

by Zacks Equity Research

Applied DNA Sciences (APDN) delivered earnings and revenue surprises of -91.67% and -50.51%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

Will Applied DNA Sciences (APDN) Report Negative Q3 Earnings? What You Should Know

by Zacks Equity Research

Applied DNA Sciences (APDN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.